AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33628786 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple parasitism (Ascaris lumbricoides + Trichuris trichiura + hookworm)
Number of subjects: 788
Study 33628786 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall prevalence
Number of subjects: 788
Study 33628786 — intervention group
Group type: EXPERIMENTAL
Intervention: Infection by sex
Number of subjects: 788
Study 33628786 — intervention group
Group type: EXPERIMENTAL
Intervention: Infection by age
Number of subjects: 788
Study 33628786 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational level
Number of subjects: 788
Study 33628786 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal concentration of eggs
Number of subjects: 788
Study 35209755 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly objectified images of women in alcohol advertisements
Number of subjects: 1208
Study 35209755 — intervention group
Group type: COMPARATOR
Intervention: Low-objectified images of women in alcohol advertisements
Number of subjects: 1208
Study 35209755 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to highly objectified advertisements
Number of subjects: 1208
Study 35209755 — intervention group
Group type: EXPERIMENTAL
Intervention: Wishful identification with models in alcohol advertisements
Number of subjects: 1208
Study 35209755 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived realism of alcohol ads
Number of subjects: 1208
Study 35209755 — intervention group
Group type: EXPERIMENTAL
Intervention: Interaction between wishful identification and perceived realism
Number of subjects: 1208
Study 34571605 — intervention group
Group type: EXPERIMENTAL
Intervention: Blink-Blink software with 8 reminders/min
Number of subjects: 46
Study 34571605 — intervention group
Group type: COMPARATOR
Intervention: Control group with 1 reminder/min
Number of subjects: 46
Study 32758152 — intervention group
Group type: EXPERIMENTAL
Intervention: Manufactured UDCA (300 mg tablets and capsules)
Number of subjects: 30
Study 32758152 — intervention group
Group type: COMPARATOR
Intervention: Standard UDCA
Number of subjects: 30
Study 34340911 — intervention group
Group type: EXPERIMENTAL
Intervention: Total polyphenol and flavonoid intake
Number of subjects: 6633
Study 34340911 — intervention group
Group type: EXPERIMENTAL
Intervention: Lignan intake
Number of subjects: 6633
Study 34340911 — intervention group
Group type: EXPERIMENTAL
Intervention: Stilbene intake
Number of subjects: 6633
Study 34340911 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenolic acid intake
Number of subjects: 6633
Study 34340911 — intervention group
Group type: EXPERIMENTAL
Intervention: Other polyphenol classes
Number of subjects: 6633
Study 34340911 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyphenol intake in women
Number of subjects: 6633
Study 34340911 — intervention group
Group type: EXPERIMENTAL
Intervention: Consumption of 'other polyphenols' class
Number of subjects: 6633
Study 33113571 — intervention group
Group type: EXPERIMENTAL
Intervention: Apalutamide plus ADT
Number of subjects: 0
Study 33113571 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus ADT
Number of subjects: 0
Study 35088697 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss intervention
Number of subjects: 49
Study 35088697 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 49
Study 35088697 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 49
Study 33041172 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensor-guided knee balancing
Number of subjects: 152
Study 33041172 — intervention group
Group type: COMPARATOR
Intervention: Standard gap balancing (control)
Number of subjects: 152
Study 32886868 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight-bearing functional exercise
Number of subjects: 22
Study 32886868 — intervention group
Group type: COMPARATOR
Intervention: Non-weight-bearing quadriceps strengthening exercise
Number of subjects: 22
Study 33388532 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 digital subtraction angiography (DSA)
Number of subjects: 50
Study 33388532 — intervention group
Group type: COMPARATOR
Intervention: ICM digital subtraction angiography (DSA)
Number of subjects: 50
Study 33079238 — intervention group
Group type: COMPARATOR
Intervention: Conventional laparoscopic instruments (CLI)
Number of subjects: 50
Study 33079238 — intervention group
Group type: EXPERIMENTAL
Intervention: Motorized articulating laparoscopic instruments (ALI)
Number of subjects: 50
Study 33079238 — intervention group
Group type: EXPERIMENTAL
Intervention: Both CLI and ALI
Number of subjects: 50
Study 33046461 — intervention group
Group type: EXPERIMENTAL
Intervention: Cataract surgical coverage (CSC) for persons with visual acuity <3/60
Number of subjects: 4078
Study 33046461 — intervention group
Group type: EXPERIMENTAL
Intervention: Cataract surgeries with poor visual outcome
Number of subjects: 4078
Study 33046461 — intervention group
Group type: EXPERIMENTAL
Intervention: Effective cataract surgical coverage (eCSC)
Number of subjects: 4078
Study 33046461 — intervention group
Group type: EXPERIMENTAL
Intervention: Prevalence of blindness
Number of subjects: 4078
Study 33046461 — intervention group
Group type: EXPERIMENTAL
Intervention: Prevalence of severe vision impairment
Number of subjects: 4078
Study 33046461 — intervention group
Group type: EXPERIMENTAL
Intervention: Prevalence of moderate vision impairment
Number of subjects: 4078
Study 33046461 — intervention group
Group type: EXPERIMENTAL
Intervention: Causes of blindness
Number of subjects: 4078
Study 33046461 — intervention group
Group type: EXPERIMENTAL
Intervention: Most frequently reported barrier to cataract surgery
Number of subjects: 4078
Study 85068751 — intervention group
Group type: EXPERIMENTAL
Intervention: Amantadine 100 mg
Number of subjects: 0
Study 85068751 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine 2.5 + 2.5 mg
Number of subjects: 0
Study 85068751 — intervention group
Group type: COMPARATOR
Intervention: Ethanol (1 g/kg)
Number of subjects: 0
Study 85068751 — intervention group
Group type: EXPERIMENTAL
Intervention: Amantadine and bromocriptine (combined with ethanol)
Number of subjects: 0
Study 35523116 — intervention group
Group type: EXPERIMENTAL
Intervention: Cissus quadrangularis 1.6 g/day (CQ1.6)
Number of subjects: 134
Study 35523116 — intervention group
Group type: EXPERIMENTAL
Intervention: Cissus quadrangularis 1.2 g/day (CQ1.2)
Number of subjects: 134
Study 35523116 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 134
Study 34032127 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-accelerated catheter-directed thrombolysis
Number of subjects: 120
Study 34032127 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment alone
Number of subjects: 120
Study 34137830 — intervention group
Group type: EXPERIMENTAL
Intervention: Volar locking plate system (VLPS)
Number of subjects: 304
Study 34137830 — intervention group
Group type: EXPERIMENTAL
Intervention: External fixation with or without supplementary pinning (EFP)
Number of subjects: 304
Study 34137830 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous pinning (CRPP)
Number of subjects: 304
Study 34137830 — intervention group
Group type: COMPARATOR
Intervention: Closed reduction and casting
Number of subjects: 304
Study 34137830 — intervention group
Group type: COMPARATOR
Intervention: Casting
Number of subjects: 304
Study 34137830 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 304
Study 32007650 — intervention group
Group type: EXPERIMENTAL
Intervention: 18F‐FDG‐PET‐CT in PMR patients
Number of subjects: 101
Study 32007650 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-PMR population)
Number of subjects: 101
Study 34978133 — intervention group
Group type: EXPERIMENTAL
Intervention: PRP prepared by digital centrifuge, large-sized sodium citrate tube, and low centrifugation speed (900 rpm)
Number of subjects: 40
Study 34978133 — intervention group
Group type: EXPERIMENTAL
Intervention: PRP treatment (all groups)
Number of subjects: 40
Study 34978133 — intervention group
Group type: COMPARATOR
Intervention: PRP prepared by different methods (4 groups)
Number of subjects: 40
Study 34375388 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss diet intervention
Number of subjects: 457
Study 34710240 — intervention group
Group type: EXPERIMENTAL
Intervention: Oscillating chitosan brush
Number of subjects: 78
Study 34710240 — intervention group
Group type: COMPARATOR
Intervention: Regular curettes
Number of subjects: 78
Study 32621657 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid injections using a stamp-type microneedle (Dermashine balance)
Number of subjects: 60
Study 32621657 — intervention group
Group type: COMPARATOR
Intervention: Placebo injections
Number of subjects: 60
Study 35938326 — intervention group
Group type: EXPERIMENTAL
Intervention: Naochang Tongtiao acupuncture
Number of subjects: 64
Study 35938326 — intervention group
Group type: COMPARATOR
Intervention: Conventional acupuncture
Number of subjects: 64
Study 33359375 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucocorticoids
Number of subjects: 0
Study 35113582 — intervention group
Group type: EXPERIMENTAL
Intervention: Prevention and Relationship Education Program (PREP)
Number of subjects: 242
Study 32048170 — intervention group
Group type: EXPERIMENTAL
Intervention: MQFRMP (Modified Qufeng Runmian Powder)
Number of subjects: 220
Study 32048170 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 220
Study 36450853 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole body massage
Number of subjects: 74
Study 36450853 — intervention group
Group type: COMPARATOR
Intervention: Oral 10% dextrose
Number of subjects: 74
Study 36450853 — intervention group
Group type: COMPARATOR
Intervention: Kangaroo care
Number of subjects: 74
Study 33615641 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mM denatonium benzoate solution (0.1 ml/kg)
Number of subjects: 20
Study 33615641 — intervention group
Group type: COMPARATOR
Intervention: Placebo (water, identical volume)
Number of subjects: 20
Study 32059641 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative quality improvement program
Number of subjects: 10000
Study 32059641 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 10000
Study 34399643 — intervention group
Group type: EXPERIMENTAL
Intervention: Infographics
Number of subjects: 280
Study 34399643 — intervention group
Group type: COMPARATOR
Intervention: Text
Number of subjects: 280
Study 33502122 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein diet (30% protein, 40% carbohydrates, 30% fat)
Number of subjects: 76
Study 33502122 — intervention group
Group type: COMPARATOR
Intervention: Standard-protein diet (15% protein, 55% carbohydrates, 30% fat)
Number of subjects: 76
Study 33112544 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D-HD laparoscope
Number of subjects: 120
Study 33112544 — intervention group
Group type: COMPARATOR
Intervention: 2D-HD laparoscope
Number of subjects: 120
Study 36328387 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic laparoscopy with excision of endometrial tissue (active surgery)
Number of subjects: 100
Study 36328387 — intervention group
Group type: EXPERIMENTAL
Intervention: Purely diagnostic laparoscopy (sham surgery)
Number of subjects: 100
Study 36328387 — intervention group
Group type: COMPARATOR
Intervention: Delayed surgery (no-surgery control group)
Number of subjects: 100
Study 35662680 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenting Acceptance and Commitment Therapy (PACT)
Number of subjects: 67
Study 32706692 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based self-management support in addition to usual care (n=33)
Number of subjects: 62
Study 32706692 — intervention group
Group type: COMPARATOR
Intervention: Usual care only (n=29)
Number of subjects: 62
Study 36153482 — intervention group
Group type: EXPERIMENTAL
Intervention: Invitation letter with researcher photographs (IG)
Number of subjects: 9990
Study 36153482 — intervention group
Group type: COMPARATOR
Intervention: Invitation letter without photographs (CG)
Number of subjects: 9990
Study 34784247 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin treatment with acute exercise
Number of subjects: 44
Study 34784247 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 weeks of exercise training
Number of subjects: 44
Study 34784247 — intervention group
Group type: COMPARATOR
Intervention: Control group (no metformin) with acute exercise
Number of subjects: 44
Study 34784247 — intervention group
Group type: COMPARATOR
Intervention: Control group (no metformin) with 12 weeks of exercise training
Number of subjects: 44
Study 34590924 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand-assisted laparoscopic surgery (HALS)
Number of subjects: 124
Study 34590924 — intervention group
Group type: COMPARATOR
Intervention: Open surgery (OS)
Number of subjects: 124
Study 32019700 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% atropine
Number of subjects: 383
Study 32019700 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.025% atropine
Number of subjects: 383
Study 32019700 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.01% atropine
Number of subjects: 383
Study 32019700 — intervention group
Group type: COMPARATOR
Intervention: 0.05% atropine (phase 1 placebo switched to 0.05% in second year)
Number of subjects: 383
Study 35262718 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily low-dose aspirin (81 mg) taken at least 5 of 7 days per week for at least 80% of follow-up time
Number of subjects: 1227
Study 35262718 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1227
Study 33852732 — intervention group
Group type: EXPERIMENTAL
Intervention: Yellow cassava pasta enriched with amaranth vegetable
Number of subjects: 0
Study 33852732 — intervention group
Group type: EXPERIMENTAL
Intervention: Yellow cassava pasta
Number of subjects: 0
Study 33852732 — intervention group
Group type: EXPERIMENTAL
Intervention: Ugwu (Telfairia occidentalis)
Number of subjects: 0
Study 35894657 — intervention group
Group type: EXPERIMENTAL
Intervention: C21 (200 mg)
Number of subjects: 12
Study 35894657 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 33200309 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic Sleeve Gastrectomy (LSG)
Number of subjects: 201
Study 33200309 — intervention group
Group type: COMPARATOR
Intervention: One-Anastomosis Gastric Bypass (OAGB)
Number of subjects: 201
Study 32331922 — intervention group
Group type: EXPERIMENTAL
Intervention: Activated photochromic lens
Number of subjects: 60
Study 32331922 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactivated photochromic lens
Number of subjects: 60
Study 32331922 — intervention group
Group type: COMPARATOR
Intervention: Non‐photochromic lens
Number of subjects: 60
Study 32079891 — intervention group
Group type: EXPERIMENTAL
Intervention: Open reduction
Number of subjects: 234
Study 32079891 — intervention group
Group type: COMPARATOR
Intervention: Closed reduction
Number of subjects: 234
Study 36327320 — intervention group
Group type: EXPERIMENTAL
Intervention: DNA/AIDSVAX BE
Number of subjects: 0
Study 36327320 — intervention group
Group type: EXPERIMENTAL
Intervention: DNA/CN54gp140
Number of subjects: 0
Study 36327320 — intervention group
Group type: EXPERIMENTAL
Intervention: daily oral PrEP
Number of subjects: 0
Study 36327320 — intervention group
Group type: COMPARATOR
Intervention: placebo control
Number of subjects: 0
Study 36327320 — intervention group
Group type: EXPERIMENTAL
Intervention: daily Truvada
Number of subjects: 0
Study 33369459 — intervention group
Group type: EXPERIMENTAL
Intervention: Airway Block (n=30) - Superior laryngeal nerve block bilaterally and recurrent laryngeal nerve block transtracheally with Inj 2% Lignocaine
Number of subjects: 60
Study 33369459 — intervention group
Group type: COMPARATOR
Intervention: Airway Nebulization (n=30) - Airway nebulized with 4% Lignocaine with ultrasonic nebulizer
Number of subjects: 60
Study 35614028 — intervention group
Group type: EXPERIMENTAL
Intervention: EUS-FNA with self-ROSE
Number of subjects: 194
Study 35614028 — intervention group
Group type: COMPARATOR
Intervention: EUS-FNA without self-ROSE (non-self-ROSE group)
Number of subjects: 194
Study 32976362 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk reduction counseling
Number of subjects: 1050
Study 32976362 — intervention group
Group type: COMPARATOR
Intervention: STI health education control condition
Number of subjects: 1050
Study 32976362 — intervention group
Group type: COMPARATOR
Intervention: Enhanced partner notification counseling
Number of subjects: 1050
Study 32541643 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan (ARB group)
Number of subjects: 0
Study 32541643 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 36079758 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound (U group)
Number of subjects: 60
Study 36079758 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency (RF group)
Number of subjects: 60
Study 36079758 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined radiofrequency and ultrasound (RF/U group)
Number of subjects: 60
Study 32886181 — intervention group
Group type: EXPERIMENTAL
Intervention: scHA/budesonide
Number of subjects: 30
Study 32886181 — intervention group
Group type: COMPARATOR
Intervention: scHA
Number of subjects: 30
Study 36328945 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive Muscle Relaxation (PMR)
Number of subjects: 0
Study 36328945 — intervention group
Group type: COMPARATOR
Intervention: Control group (no PMR)
Number of subjects: 0
Study 32687819 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral weight loss intervention (health coaching phone sessions weekly for 6 months, then monthly for 18 months or until end of pregnancy)
Number of subjects: 326
Study 32687819 — intervention group
Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 326
Study 32687819 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral weight loss intervention
Number of subjects: 326
Study 35329133 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone follow-up (test)
Number of subjects: 60
Study 35329133 — intervention group
Group type: COMPARATOR
Intervention: Conventional personal aftercare (control)
Number of subjects: 60
Study 36324088 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tACS plus VST (visual scanning training)
Number of subjects: 22
Study 36324088 — intervention group
Group type: COMPARATOR
Intervention: Sham (placebo) tACS plus VST (visual scanning training)
Number of subjects: 22
Study 33691499 — intervention group
Group type: EXPERIMENTAL
Intervention: M. vaccae in combination with standard care
Number of subjects: 31
Study 33691499 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 31
Study 36083814 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily intravenous infusions of ozonized saline with ozone concentration of 2.0 mg/l for 5 days followed by standard rehabilitation (n=18)
Number of subjects: 51
Study 36083814 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 ozone therapy procedures every other day (n=16)
Number of subjects: 51
Study 36083814 — intervention group
Group type: COMPARATOR
Intervention: Control group with a 10-day course of daily breathing exercises and physiotherapy for the lungs (n=17)
Number of subjects: 51
Study 36048457 — intervention group
Group type: EXPERIMENTAL
Intervention: Telaglenastat plus Cabozantinib (Tela + Cabo)
Number of subjects: 444
Study 36048457 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus Cabozantinib (Pbo + Cabo)
Number of subjects: 444
Study 33020113 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised airway clearance techniques (ACT) lasting 30-60 min
Number of subjects: 64
Study 33020113 — intervention group
Group type: COMPARATOR
Intervention: Rest
Number of subjects: 64
Study 35973593 — intervention group
Group type: EXPERIMENTAL
Intervention: 577nm subthreshold micropulse laser (SML)
Number of subjects: 266
Study 35973593 — intervention group
Group type: COMPARATOR
Intervention: Standard laser (SL)
Number of subjects: 266
Study 35973593 — intervention group
Group type: EXPERIMENTAL
Intervention: SML
Number of subjects: 266
Study 35973593 — intervention group
Group type: EXPERIMENTAL
Intervention: SML and SL
Number of subjects: 266
Study 33798494 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic surgical closure of the left atrial appendage
Number of subjects: 1040
Study 32232974 — intervention group
Group type: EXPERIMENTAL
Intervention: Androgen deprivation therapy (ADT)
Number of subjects: 20
Study 35925157 — intervention group
Group type: EXPERIMENTAL
Intervention: PMD200 monitoring with sufentanil bolus administered when NoL index > 25 for 2 min (n=24)
Number of subjects: 50
Study 35925157 — intervention group
Group type: COMPARATOR
Intervention: Standardized sufentanil bolus administered at anesthesiologist's discretion (n=26)
Number of subjects: 50
Study 32222430 — intervention group
Group type: EXPERIMENTAL
Intervention: Definitive thoracic radiation therapy (RT) administered once or twice daily for LS-SCLC
Number of subjects: 0
Study 32222430 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant RT in surgically resected patients with positive margins or nodal metastases
Number of subjects: 0
Study 32222430 — intervention group
Group type: EXPERIMENTAL
Intervention: Involved field RT using conformal advanced treatment modalities to postchemotherapy volumes
Number of subjects: 0
Study 32222430 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic body radiation therapy (SBRT) or conventional fractionation for stage I or II node negative disease
Number of subjects: 0
Study 32222430 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic cranial irradiation (PCI) for LS-SCLC
Number of subjects: 0
Study 32222430 — intervention group
Group type: EXPERIMENTAL
Intervention: Consultation for consideration of PCI versus magnetic resonance surveillance in ES-SCLC
Number of subjects: 0
Study 32222430 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic RT in select patients with ES-SCLC after chemotherapy treatment
Number of subjects: 0
Study 34388698 — intervention group
Group type: EXPERIMENTAL
Intervention: Palbociclib (125 mg/d on a 3 weeks on/1 week off schedule) plus letrozole (2.5 mg/d, continuous)
Number of subjects: 0
Study 34388698 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus letrozole
Number of subjects: 0
Study 32629906 — intervention group
Group type: EXPERIMENTAL
Intervention: Gluten-free, low FODMAP diet during elimination phase
Number of subjects: 11
Study 33801216 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearable focal muscle vibration (FMV) therapy applied using a modified MyovoltTM device, 3 days a week for 4 weeks
Number of subjects: 23
Study 33801216 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearable focal muscle vibration (FMV) therapy
Number of subjects: 23